Cefuroxime recalls
The FDA has published 6 recalls involving Cefuroxime since 2016. The latest was reported on 25 Oct 2023. Most were for sterility. JCB Laboratories has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls6since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 25 Oct 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 5 83%Class III 1 17%
Why cefuroxime is recalled
Companies
By year
All cefuroxime recalls, newest first
6 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Cefuroxime 4mg / (10 mg/mL) syringe recalled by Pine Pharmaceuticals | Pine Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | Cefuroxime, Sterile Ophthalmic Solution for Injection recalled | Edge Pharma | Sterility | Nationwide |
| Drug | CLASS II | Cefuroxime 10mg/mL INJ 0.5 mg, SDV recalled | Pacific Compounding Pharmacy & Consultations | Particulate Matter | CA |
| Drug | CLASS II | Cefuroxime 10 mg/mL in Sodium Chloride recalled by Leiter's Enterprises | Leiter's Enterprises | Sterility | 4 states |
| Drug | CLASS III | Cefuroxime, Ophthalmic Solution for Injection recalled | JCB Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Cefuroxime Sodium 10 mg/mL in 0.9% Sodium Chloride recalled | Leiter's Compounding | Sterility | Nationwide |
Should you stop taking Cefuroxime?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.